ROTH DAVID (Chief Medical Officer) sold 12.10K shares of SYROS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.4K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2024ACC: 0000950170-24-129383
Officer· Chief Medical Officer
Since Feb 2019
-12.10K
Net shares
Net seller
$2.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
12.10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−12.10K
Price / share
$0.20
Trade value
$2.38K
% of position
New position
11/18/2024
12.10K→0.00
Total
Net shares
−12.10K
Net value
-$2.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2024 | S · Sale | −12.10K | $0.20 | $2.38K | New position | 12.10K | 0.00 |
| Total | −12.10K | -$2.38K | ||||||
Derivative Transactions0
No derivative transactions reported